mortality/aging
• to low dosages of LPS
|
homeostasis/metabolism
• increased monocyte chemoattractant protein-1 (MCP-1), and RANTES (regulated upon activation, normal T-cell expressed and secreted) 6hr after LPS injection
|
• increased monocyte chemoattractant protein-1 (MCP-1) levels in liver and lung and increased RANTES (regulated upon activation, normal T-cell expressed) in the spleen and lung 6 hrs after LPS injection.
• increased monocyte chemoattractant protein-1 (MCP-1) by peritoneal macrophages cultured with LPS or heat-killed bacteria
|
• to low dosages of LPS
|
immune system
• increased monocyte chemoattractant protein-1 (MCP-1), and RANTES (regulated upon activation, normal T-cell expressed and secreted) 6hr after LPS injection
|
• increased monocyte chemoattractant protein-1 (MCP-1) levels in liver and lung and increased RANTES (regulated upon activation, normal T-cell expressed) in the spleen and lung 6 hrs after LPS injection.
• increased monocyte chemoattractant protein-1 (MCP-1) by peritoneal macrophages cultured with LPS or heat-killed bacteria
|
• IL6 levels were also elevated in the spleen, liver, and lung
• by peritoneal macrophages cultured with LPS or heat-killed bacteria
|